(Q37826158)

23 August 2017

1 reference

title

Eurogin 2010 roadmap on cervical cancer prevention (English)

1 reference

23 August 2017

main subject

cervix uterine cancer

1 reference

Pier Luigi Lopalco

5

0 references

Peter Sasieni

object named as

Peter Sasieni

9

0 references

Silvia Franceschi

object named as

Silvia Franceschi

1

0 references

Julian Peto

7

object named as

Julian Peto

1 reference

23 August 2017

10

Cosette M Wheeler

1 reference

23 August 2017

Lynette Denny

2

1 reference

23 August 2017

Kathleen L Irwin

3

1 reference

23 August 2017

José Jeronimo

4

1 reference

23 August 2017

Joseph Monsonego

6

1 reference

23 August 2017

Guglielmo Ronco

8

1 reference

23 August 2017

language of work or name

English

0 references

publication date

25 March 2011

1 reference

International Journal of Cancer

23 August 2017

published in

1 reference

23 August 2017

volume

128

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

2765-2774

1 reference

23 August 2017

cites work

Age for HPV vaccination

1 reference

Is viral status needed before vaccination?

21 January 2018

1 reference

Cervical cancer screening following prophylactic human papillomavirus vaccination

21 January 2018

1 reference

Immunobiology of HPV and HPV vaccines

21 January 2018

1 reference

EUROGIN 2008 roadmap on cervical cancer prevention

21 January 2018

1 reference

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

21 January 2018

1 reference

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

21 January 2018

1 reference

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

21 January 2018

1 reference

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

21 January 2018

1 reference

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

21 January 2018

1 reference

Further analysis of the ARTISTIC trial

21 January 2018

1 reference

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

21 January 2018

1 reference

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period

21 January 2018

1 reference

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

21 January 2018

1 reference

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

21 January 2018

1 reference

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

21 January 2018

1 reference

A critical assessment of screening methods for cervical neoplasia

21 January 2018

1 reference

The prevention of cervical cancer in developing countries

21 January 2018

1 reference

Different cervical cancer screening approaches in a Chinese multicentre study

21 January 2018

1 reference

Inappropriate gold standard bias in cervical cancer screening studies

21 January 2018

1 reference

Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial

21 January 2018

1 reference

HPV screening for cervical cancer in rural India

21 January 2018

1 reference

Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial

21 January 2018

1 reference

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

21 January 2018

1 reference

Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.

21 January 2018

1 reference

Prevention of cervical cancer in women with HIV.

21 January 2018

1 reference

Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women

21 January 2018

1 reference

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

21 January 2018

1 reference

Human papillomavirus vaccine coverage

21 January 2018

1 reference

Preparing for HPV vaccination in South Africa: key challenges and opinions.

21 January 2018

1 reference

Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings

21 January 2018

1 reference

Evaluation of the thermal stability of Gardasil.

21 January 2018

1 reference

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

21 January 2018

1 reference

Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement

21 January 2018

1 reference

Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines

21 January 2018

1 reference

EUROGIN 2007 roadmap—Conclusion

21 January 2018

1 reference

Cash crisis looms for vaccine drive

21 January 2018

1 reference

The India HPV-vaccine suspension

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25915

1 reference

23 August 2017

1 reference